awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42203535-F98004F5-87D1-40D9-BA07-56621A959436
Q42203535-F98004F5-87D1-40D9-BA07-56621A959436
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42203535-F98004F5-87D1-40D9-BA07-56621A959436
The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.
P2860
Q42203535-F98004F5-87D1-40D9-BA07-56621A959436
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42203535-F98004F5-87D1-40D9-BA07-56621A959436
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f14b3e6120d1f84b833195b7d7e1ad07ee982e43
P2860
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.